These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10955810

  • 1. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
    Collett GP, Betts AM, Johnson MI, Pulimood AB, Cook S, Neal DE, Robson CN.
    Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
    [Abstract] [Full Text] [Related]

  • 2. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP.
    Cancer Res; 2000 Oct 01; 60(19):5494-8. PubMed ID: 11034093
    [Abstract] [Full Text] [Related]

  • 3. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G.
    Cancer Res; 1997 Mar 15; 57(6):1086-90. PubMed ID: 9067276
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
    Xu LL, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW, Carter KC, Srivastava S.
    J Urol; 2000 Mar 15; 163(3):972-9. PubMed ID: 10688034
    [Abstract] [Full Text] [Related]

  • 6. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN.
    Cancer Res; 2001 Jan 15; 61(2):497-503. PubMed ID: 11212240
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Jan 15; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ.
    Mol Carcinog; 2002 Aug 15; 34(4):165-71. PubMed ID: 12203367
    [Abstract] [Full Text] [Related]

  • 10. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 11. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ.
    Cancer Res; 2004 Jun 01; 64(11):3849-54. PubMed ID: 15172993
    [Abstract] [Full Text] [Related]

  • 12. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.
    Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
    Tien ES, Gray JP, Peters JM, Vanden Heuvel JP.
    Cancer Res; 2003 Sep 15; 63(18):5767-80. PubMed ID: 14522898
    [Abstract] [Full Text] [Related]

  • 15. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, Gleave ME, Nelson CC.
    Prostate; 2004 May 15; 59(3):337-49. PubMed ID: 15042610
    [Abstract] [Full Text] [Related]

  • 16. Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes.
    Hartel A, Didier A, Ulbrich SE, Wierer M, Meyer HH.
    J Steroid Biochem Mol Biol; 2004 Oct 15; 92(3):187-97. PubMed ID: 15555912
    [Abstract] [Full Text] [Related]

  • 17. High-level expression of RXRalpha and the presence of endogenous ligands contribute to expression of a peroxisome proliferator-activated receptor-responsive gene in hepatoma cells.
    Galli A, Stewart M, Dorris R, Crabb D.
    Arch Biochem Biophys; 1998 Jun 15; 354(2):288-94. PubMed ID: 9637738
    [Abstract] [Full Text] [Related]

  • 18. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN.
    Br J Cancer; 2001 Dec 14; 85(12):1928-36. PubMed ID: 11747336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
    Jiang F, Wang Z.
    Prostate; 2004 Jun 01; 59(4):426-35. PubMed ID: 15065091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.